Every day, headlines detail the casualties of the nation’s surge in heroin and prescription painkiller abuse: the funerals, the broken families and the patients cycling in and out of treatment. Now, a new study sheds light on another repercussion
At some hospitals, posters on the wall in the emergency department list the drugs that are in short supply or unavailable, along with recommended alternatives.
Medicare beneficiaries may get dinged with higher prescription drug bills this year because more than half of covered drugs in standalone plans require them to pay a percentage of the cost rather than a flat fee, a new analysis found.
Aetna and Cigna inked deals in early February with drugmaker Novartis that offer the insurers rebates tied to how well a pricey new heart failure drug works to cut hospitalizations and deaths. If the $4,500-a-year drug meets targets, the rebate goes down. Doesn’t work so well?
Rep. Knute Buehler, R-Bend, is promoting a bill that would give pharmacists the ability to quickly dispense a life-saving drug for use in opiate overdoses without the prescription of one of his fellow physicians.
Rep. Rob Nosse, D-Portland, is bringing back a bill that requires pharmacists to give extra notification to medication prescribers when the pharmacist dispenses a cheaper, biosimilar equivalent to a brand-name biological drug.
Prescription painkiller abuse is drawing national attention as states battle increasing abuse cases, presidential candidates offer possible solutions and even President Barack Obama includes the issue in his State of the Union address Tuesday night.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
In an unprecedented decision, the Center for Medicare & Medicaid Services has published comprehensive data showing which physicians and other healthcare providers prescribed the highest number of drugs – by cost, claim and their type – to Medicare beneficiaries.1